Dempze Nancy E - NOVOZYMES A S DKK 2.0 ownership

NOVOZYMES A S DKK 2.0's ticker is and the CUSIP is B798FW902. A total of 8 filers reported holding NOVOZYMES A S DKK 2.0 in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
Dempze Nancy E ownership history of NOVOZYMES A S DKK 2.0
ValueSharesWeighting
Q1 2022$426,000
-42.4%
6,199
-31.3%
0.31%
-37.7%
Q4 2021$740,000
-15.9%
9,024
-29.9%
0.50%
-27.7%
Q3 2021$880,000
-29.8%
12,874
-22.8%
0.69%
-34.7%
Q2 2021$1,254,000
-22.2%
16,667
-34.0%
1.06%
-25.8%
Q1 2021$1,612,000
+4.8%
25,244
-6.0%
1.42%
+0.8%
Q4 2020$1,538,000
-8.2%
26,868
+0.9%
1.41%
-16.9%
Q3 2020$1,675,000
+8.1%
26,628
-1.0%
1.70%
-1.7%
Q2 2020$1,549,000
+26.9%
26,893
+0.4%
1.73%
+5.4%
Q1 2020$1,221,000
-2.9%
26,788
+3.9%
1.64%
+17.9%
Q4 2019$1,258,000
+16.9%
25,779
+0.5%
1.39%
+7.0%
Q3 2019$1,076,000
-15.8%
25,655
-6.7%
1.30%
-11.2%
Q2 2019$1,278,000
+1.3%
27,492
-0.1%
1.47%
-1.4%
Q1 2019$1,261,000
+4.3%
27,512
+1.5%
1.49%
-11.5%
Q4 2018$1,209,000
-23.1%
27,112
-5.5%
1.68%
-4.6%
Q3 2018$1,572,000
+7.1%
28,695
-0.9%
1.76%
-1.9%
Q2 2018$1,468,000
-1.2%
28,965
+0.5%
1.80%
-2.1%
Q1 2018$1,486,000
-11.9%
28,825
-2.6%
1.83%
-10.0%
Q4 2017$1,687,000
+29.5%
29,600
+16.4%
2.04%
+10.9%
Q3 2017$1,303,000
+17.8%
25,437
+0.6%
1.84%
+15.8%
Q2 2017$1,106,0000.0%25,277
-9.3%
1.59%
-6.3%
Q1 2017$1,106,000
+23.7%
27,880
+7.5%
1.69%
+8.1%
Q4 2016$894,000
-15.7%
25,935
+7.7%
1.57%
-15.6%
Q3 2016$1,060,000
-6.5%
24,080
+2.1%
1.86%
-8.1%
Q2 2016$1,134,000
+14.7%
23,590
+7.2%
2.02%
+16.4%
Q1 2016$989,000
+26.3%
22,000
+35.4%
1.74%
+15.1%
Q4 2015$783,00016,2501.51%
Other shareholders
NOVOZYMES A S DKK 2.0 shareholders Q4 2020
NameSharesValueWeighting ↓
SOMERVILLE KURT F 201,293$11,524,0001.88%
Broderick Brian C 103,399$5,920,0001.76%
PUZO MICHAEL J 87,630$5,016,0001.64%
Page Arthur B 37,110$2,124,0001.60%
Kidder Stephen W 82,525$4,725,0001.57%
Dempze Nancy E 26,868$1,538,0001.41%
Hemenway Trust Co LLC 206,884$11,844,0001.36%
Notis-McConarty Edward 32,876$1,882,0000.77%
View complete list of NOVOZYMES A S DKK 2.0 shareholders